JP2021192835A5 - - Google Patents

Download PDF

Info

Publication number
JP2021192835A5
JP2021192835A5 JP2021150228A JP2021150228A JP2021192835A5 JP 2021192835 A5 JP2021192835 A5 JP 2021192835A5 JP 2021150228 A JP2021150228 A JP 2021150228A JP 2021150228 A JP2021150228 A JP 2021150228A JP 2021192835 A5 JP2021192835 A5 JP 2021192835A5
Authority
JP
Japan
Prior art keywords
brain
subject
blood
substance
period
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021150228A
Other languages
English (en)
Japanese (ja)
Other versions
JP7667045B6 (ja
JP7667045B2 (ja
JP2021192835A (ja
Filing date
Publication date
Priority claimed from JP2020573539A external-priority patent/JP6974671B2/ja
Application filed filed Critical
Publication of JP2021192835A publication Critical patent/JP2021192835A/ja
Publication of JP2021192835A5 publication Critical patent/JP2021192835A5/ja
Priority to JP2025064456A priority Critical patent/JP2025106473A/ja
Application granted granted Critical
Publication of JP7667045B2 publication Critical patent/JP7667045B2/ja
Publication of JP7667045B6 publication Critical patent/JP7667045B6/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021150228A 2018-08-23 2021-09-15 血液脳関門の透過性を向上させるための交流電界の使用 Active JP7667045B6 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025064456A JP2025106473A (ja) 2018-08-23 2025-04-09 血液脳関門の透過性を向上させるための交流電界の使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862722100P 2018-08-23 2018-08-23
US62/722,100 2018-08-23
JP2020573539A JP6974671B2 (ja) 2018-08-23 2019-08-22 血液脳関門の透過性を向上させるための交流電界の使用

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020573539A Division JP6974671B2 (ja) 2018-08-23 2019-08-22 血液脳関門の透過性を向上させるための交流電界の使用

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025064456A Division JP2025106473A (ja) 2018-08-23 2025-04-09 血液脳関門の透過性を向上させるための交流電界の使用

Publications (4)

Publication Number Publication Date
JP2021192835A JP2021192835A (ja) 2021-12-23
JP2021192835A5 true JP2021192835A5 (enExample) 2022-08-30
JP7667045B2 JP7667045B2 (ja) 2025-04-22
JP7667045B6 JP7667045B6 (ja) 2025-06-05

Family

ID=68104708

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2020573539A Active JP6974671B2 (ja) 2018-08-23 2019-08-22 血液脳関門の透過性を向上させるための交流電界の使用
JP2021007072A Active JP7233453B2 (ja) 2018-08-23 2021-01-20 血液脳関門の透過性を向上させるための交流電界の使用
JP2021150228A Active JP7667045B6 (ja) 2018-08-23 2021-09-15 血液脳関門の透過性を向上させるための交流電界の使用
JP2025064456A Pending JP2025106473A (ja) 2018-08-23 2025-04-09 血液脳関門の透過性を向上させるための交流電界の使用

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2020573539A Active JP6974671B2 (ja) 2018-08-23 2019-08-22 血液脳関門の透過性を向上させるための交流電界の使用
JP2021007072A Active JP7233453B2 (ja) 2018-08-23 2021-01-20 血液脳関門の透過性を向上させるための交流電界の使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025064456A Pending JP2025106473A (ja) 2018-08-23 2025-04-09 血液脳関門の透過性を向上させるための交流電界の使用

Country Status (17)

Country Link
US (5) US11400269B2 (enExample)
EP (6) EP3892219B1 (enExample)
JP (4) JP6974671B2 (enExample)
KR (3) KR102651496B1 (enExample)
CN (6) CN113908433B (enExample)
AU (2) AU2019324585C1 (enExample)
BR (1) BR112020025422A2 (enExample)
CA (2) CA3100817C (enExample)
DK (4) DK3773291T3 (enExample)
ES (4) ES2911526T3 (enExample)
FI (1) FI3878389T3 (enExample)
HU (3) HUE059062T2 (enExample)
IL (2) IL279466B2 (enExample)
MX (5) MX2020013519A (enExample)
PL (3) PL3804648T3 (enExample)
SG (1) SG11202012592WA (enExample)
WO (1) WO2020039390A1 (enExample)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10779875B2 (en) 2013-05-06 2020-09-22 Novocure Gmbh Optimizing treatment using TTfields by changing the frequency during the course of long term tumor treatment
US10188851B2 (en) 2015-10-28 2019-01-29 Novocure Limited TTField treatment with optimization of electrode positions on the head based on MRI-based conductivity measurements
US10821283B2 (en) 2016-04-04 2020-11-03 Novocure Gmbh Reducing motility of cancer cells using tumor treating fields (TTFields)
US20180001075A1 (en) 2016-06-30 2018-01-04 Novocure Limited Arrays for Longitudinal Delivery of TTFields to a Body
WO2018134733A1 (en) 2017-01-19 2018-07-26 Moshe Giladi System for viewing cell cultures under a microscope whilst applying ttfields
CN116159242A (zh) * 2018-07-03 2023-05-26 埃德温·阊 使用交变电场提高细胞膜通透性
KR102794415B1 (ko) 2018-07-10 2025-04-09 노보큐어 게엠베하 교류 전기장을 사용한 바이러스 감염 억제
EP3892219B1 (en) * 2018-08-23 2022-06-01 Novocure GmbH Using alternating electric fields to increase permeability of the blood brain barrier
WO2020049482A1 (en) 2018-09-07 2020-03-12 Yaniv Alon Treating autoimmune diseases using an alternating electric field to reduce the proliferation of t-cells
US11986647B2 (en) 2018-09-07 2024-05-21 Novocure Gmbh Treating autoinflammatory and mitochondrial diseases using an alternating electric field
EP3840823B1 (en) 2018-10-15 2023-07-12 Novocure GmbH Generating tumor treating fields (ttfields) with high uniformity throughout the brain
WO2020084596A1 (en) 2018-10-25 2020-04-30 Zeev Bomzon Delivering alternating electric fields (e.g., ttfields) to a subject's spinal anatomy
EP3922301B1 (en) 2018-11-19 2024-02-21 Novocure GmbH Arrays for delivering tumor treating fields (ttfields) with selectively addressable sub-elements
KR102606263B1 (ko) 2018-11-29 2023-11-23 노보큐어 게엠베하 종양처리장을 전달하는 향상된 유연성 트랜스듀서 어레이
EP3961565A1 (en) 2019-01-08 2022-03-02 Novocure GmbH Evaluating quality of segmentation of an image into different types of tissue for planning treatment using tumor treating fields (ttfields)
KR102847999B1 (ko) 2019-02-26 2025-08-21 노보큐어 게엠베하 표적 암세포들의 전기적 특징에 기초한 종양처리장 요법의 주파수 결정
EP3954314B1 (en) 2019-02-27 2025-01-08 Novocure GmbH Delivering tumor treating fields (ttfields) using implantable transducer arrays
EP3946322B1 (en) 2019-03-29 2023-09-20 Novocure GmbH Methods for restoring sensitivity to ttfields in ttfields-resistant cancer cells with ptger3 inhibitors
US11291837B2 (en) 2019-04-17 2022-04-05 Novocure Gmbh Uploading data from an isolated system without compromising isolation
JP7472264B2 (ja) 2019-07-31 2024-04-22 ノボキュア ゲーエムベーハー 頭蓋骨インプラントに埋め込まれた電極による腫瘍治療電場(ttフィールド)の印加
EP4009971A1 (en) 2019-08-05 2022-06-15 Novocure GmbH Increasing cancer cells' sensitivity to tumor treating fields (ttfields) by inhibiting il11 activity
US11890467B2 (en) 2019-08-30 2024-02-06 Novocure Gmbh Delivering tumor treating fields (TTFields) to the neck
KR102873347B1 (ko) 2019-09-10 2025-10-17 노보큐어 게엠베하 암 세포에 교번 전기장을 적용하고 체크포인트 억제제를 투여하여 암 세포의 활력성을 감소시키는 방법
US12121739B2 (en) 2019-12-31 2024-10-22 Novocure Gmbh Methods, systems, and apparatuses for managing temperatures induced by alternating fields
WO2021137085A2 (en) 2019-12-31 2021-07-08 Novocure Gmbh High voltage, high efficiency sine wave generator that prevents spikes during amplitude adjustments and switching of channels
AU2020416669A1 (en) 2019-12-31 2022-06-16 Novocure Gmbh Arrays for delivering tumor treating fields (TTFields) with individually accessible electrode elements and temperature sensors
US20210299440A1 (en) 2020-03-30 2021-09-30 Novocure Gmbh Intravenous / Intra-Spinal / Intra-Cavity / Intraventricular Delivery of TTFields (Tumor Treating Fields) for Treating Cancer and Metastases
BR112022021484A2 (pt) * 2020-04-24 2022-12-13 Novocure Gmbh Uso de campos elétricos alternados para aumentar a permeabilidade da barreira hematoencefálica
US11818943B2 (en) 2020-06-25 2023-11-14 Novocure Gmbh Fabricating organic light emitting diodes (OLEDs) using tubulin
US12114991B2 (en) 2020-09-25 2024-10-15 Novocure Gmbh Varying the metallization area on individual electrode elements in a tumor treating fields (TTFields) system to maximize current without overheating
CA3202404A1 (en) 2020-11-25 2022-06-02 Novocure Gmbh Increasing the efficacy of tumor treating fields (ttfields) by applying the ttfields at peak intensity less than half the time
WO2022130183A2 (en) * 2020-12-17 2022-06-23 Novocure Gmbh Pyroelectric-based temperature sensing of transducer arrays for applying tumor treating fields (ttfields)
CN113008403B (zh) * 2021-02-08 2022-08-12 清华大学 电场发生装置及测温电极装置
EP4240470A1 (en) 2021-02-17 2023-09-13 Novocure Gmbh Arrays for delivering tumor treating fields (ttfields) with sets of electrode elements having individually adjustable active areas
US12440680B2 (en) 2021-03-12 2025-10-14 Novocure Gmbh Methods of treating disease by skewing macrophage phenotype with alternating electric fields
EP4596025A1 (en) 2021-03-31 2025-08-06 Novocure Gmbh Impedance tomography using electrodes of a tumor treating fields (ttfields) system
US20220323753A1 (en) * 2021-04-08 2022-10-13 Novocure Gmbh Methods of Treating Neurodegenerative Disorders with Alternating Electric Fields
CN113509641A (zh) * 2021-06-29 2021-10-19 北京康源嘉成生物科技有限公司 一种非药物且非侵入性开放血脑屏障的装置和方法
WO2023275804A1 (en) 2021-06-30 2023-01-05 Novocure Gmbh Using alternating electric fields at different frequencies to increase the permeability of the blood brain barrier and also to provide other benefits
CN114099963B (zh) * 2021-12-22 2025-10-03 江苏海莱新创医疗科技有限公司 肿瘤电场治疗系统
CN118043105A (zh) * 2021-09-30 2024-05-14 诺沃库勒有限责任公司 在使用交变电场治疗受试者的同时降低电感
US20230201616A1 (en) 2021-12-29 2023-06-29 Novocure Gmbh Reducing Electrosensation Whilst Treating a Subject Using Alternating Electric Fields by Using Larger Cathodes and Smaller Anodes
CN118591405A (zh) 2021-12-30 2024-09-03 诺沃库勒有限责任公司 使用肿瘤治疗电场(ttfields)选择治疗参数值
CN114367060A (zh) * 2022-01-13 2022-04-19 深圳大学 激光交变电场联合治疗仪
MX2024010256A (es) 2022-03-30 2024-08-28 Novocure Gmbh Reducción de la electrosensación durante el tratamiento de un sujeto mediante campos eléctricos alternos mediante el emparejamiento de matrices de transductores.
MX2024010258A (es) 2022-03-30 2024-08-28 Novocure Gmbh Uso de periodos de enfriamiento intercalados para aumentar la intensidad pico de los campos de tratamiento de tumores.
WO2023242741A1 (en) 2022-06-13 2023-12-21 Novocure Gmbh Systems and methods for increasing intestinal absorption of therapeutic agents
JP2025522725A (ja) 2022-06-27 2025-07-17 ノボキュア ゲーエムベーハー 閉ループ技術を用いた、被験者を交流電場で治療すると同時の電気感覚の軽減
EP4514445A1 (en) 2022-06-30 2025-03-05 Novocure GmbH Electrode assembly for applying tumor treating fields (ttfields) that includes a plurality of thermally linked but electrically isolated graphite sheets
KR102637878B1 (ko) * 2022-09-02 2024-02-19 주식회사 뉴로스피어 대뇌병변 산화철의 전자-펜톤효과를 이용한 전기장 대뇌자극치료기기
JP2025532790A (ja) 2022-09-30 2025-10-03 ノボキュア ゲーエムベーハー 電気感覚および/または皮膚刺激を軽減するための組成物、システム、および方法
EP4561680A1 (en) 2022-09-30 2025-06-04 Novocure Gmbh Reducing electrosensation while treating a subject using alternating electric fields by deactivating selected electrode elements
CN119998010A (zh) 2022-09-30 2025-05-13 诺沃库勒有限责任公司 通过控制爬升特性在使用交变电场治疗受试者的同时降低电感应
US20240108892A1 (en) 2022-09-30 2024-04-04 Novocure Gmbh Changing the Orientation of Tumor Treating Fields (TTFields) by Adjusting the Amplitudes of Two or More Electric Fields that Are All In-Phase with Each Other
US20240207604A1 (en) 2022-12-27 2024-06-27 Novocure Gmbh Multi Channel Device for Directional Shaping of Electric Fields e.g., Tumor Treating Fields (TTFields)
US20240216679A1 (en) 2022-12-28 2024-07-04 Novocure Gmbh Positioning Electrode Elements on a Subject's Body to Provide Stronger Alternating Electric Fields (e.g.,TTFields) Without Overheating
WO2024141958A1 (en) 2022-12-29 2024-07-04 Novocure Gmbh Reducing electrosensation while treating a subject using alternating electric fields by increasing the number of steps in a ramp-up portion of a waveform
WO2024141959A1 (en) 2022-12-29 2024-07-04 Novocure Gmbh Reducing electrosensation during application of alternating electric fields by ensuring that successive increases in amplitude occur during opposite phases of an ac waveform
US12268863B2 (en) 2023-02-06 2025-04-08 Novocure Gmbh Shiftable transducer array with anisotropic material layer
EP4661950A2 (en) 2023-02-10 2025-12-17 Novocure GmbH Sequentially positioning sets of electrode arrays at nonoverlapping positions to ameliorate skin irritation during tumor treating fields (ttfields) therapy
WO2024201412A1 (en) 2023-03-31 2024-10-03 Novocure Gmbh Microneedles to overcome contact resistance
CN120957783A (zh) 2023-03-31 2025-11-14 诺沃库勒有限责任公司 通过逐渐增大旋转交变电场的幅度来降低在使用该电场治疗受试者时的电感觉
WO2025068924A1 (en) 2023-09-29 2025-04-03 Novocure Gmbh Using staggered changes in amplitude and frequency to ameliorate electrosensation during treatment with alternating electric fields
US20250108217A1 (en) 2023-09-29 2025-04-03 Novocure Gmbh Applying an Electrical Signal Using a Multi-Part Electrode Assembly, and Interrupting the Electrical Signal if the Parts Begin to Separate
WO2025068984A1 (en) 2023-09-29 2025-04-03 Novocure Gmbh Transducer arrays for tumor treating fields (ttfields) therapy that use a dedicated flex circuit to implement temperature sensing
CN119950998A (zh) * 2023-12-26 2025-05-09 杭州海莱新创医疗科技有限公司 一种电极片类型识别方法及介质
WO2025141502A1 (en) 2023-12-29 2025-07-03 Novocure Gmbh Electrode assembly for delivering alternating electric fields with peripherally-positioned temperature sensors

Family Cites Families (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1009321A1 (en) * 1995-08-29 1999-05-28 Nitto Denko Corporation Microporation of human skin for drug delivery and monitoring applications
CN1206353A (zh) * 1995-11-21 1999-01-27 E·N·勒纳 提高有机体内生物活性物质和化合物释放的装置
EP0869829A1 (en) * 1995-11-21 1998-10-14 LERNER, Eduard Naumovich Device for enhanced delivery of biologically active substances and compounds in an organism
WO1997018855A1 (en) * 1995-11-21 1997-05-29 Eduard Naumovich Lerner Device for enhanced delivery of biologically active substances and compounds in an organism
US6678553B2 (en) * 1995-11-21 2004-01-13 Intraabrain International Nv Device for enhanced delivery of biologically active substances and compounds in an organism
US6678558B1 (en) 1999-03-25 2004-01-13 Genetronics, Inc. Method and apparatus for reducing electroporation-mediated muscle reaction and pain response
US7412285B2 (en) 1999-04-09 2008-08-12 Oncostim, Inc. Method and device for treating cancer with electrical therapy in conjunction with chemotherapeutic agents and radiation therapy
US20030078499A1 (en) 1999-08-12 2003-04-24 Eppstein Jonathan A. Microporation of tissue for delivery of bioactive agents
EP2335776A1 (en) 2000-02-17 2011-06-22 Yoram Palti Method and apparatus for destroying dividing cells
US7016725B2 (en) 2001-11-06 2006-03-21 Standen Ltd. Method and apparatus for destroying dividing cells
US7599746B2 (en) 2000-02-17 2009-10-06 Standen Ltd Apparatus and method for preventing the spread of cancerous metastases and for elimination of metastases
US8447395B2 (en) 2000-02-17 2013-05-21 Novocure Ltd Treating bacteria with electric fields
US7146210B2 (en) 2000-02-17 2006-12-05 Standen Ltd. Apparatus and method for optimizing tumor treatment efficiency by electric fields
US8175698B2 (en) 2000-02-17 2012-05-08 Novocure Ltd. Treating bacteria with electric fields
US7089054B2 (en) 2002-10-02 2006-08-08 Standen Ltd. Apparatus and method for treating a tumor or the like
US7136699B2 (en) 2002-10-02 2006-11-14 Standen, Ltd. Apparatus for destroying dividing cells
US6868289B2 (en) 2002-10-02 2005-03-15 Standen Ltd. Apparatus for treating a tumor or the like and articles incorporating the apparatus for treatment of the tumor
US7565205B2 (en) 2000-02-17 2009-07-21 Standen Ltd. Treating a tumor or the like with electric fields at different orientations
US6546290B1 (en) * 2000-04-12 2003-04-08 Roamitron Holding S.A. Method and apparatus for electromedical therapy
WO2001085094A2 (en) * 2000-05-08 2001-11-15 Brainsgate Ltd. Method and apparatus for stimulating the sphenopalatine ganglion to modify properties of the bbb and cerebral blood flow
US7332313B2 (en) 2001-06-05 2008-02-19 Applied Biophysics, Inc. Electrical wounding assay for cells in vitro
US6904322B2 (en) 2002-02-15 2005-06-07 Kalaco Scientific, Inc. Transcranial electrostimulation apparatus and method
US20030171738A1 (en) 2002-03-06 2003-09-11 Konieczynski David D. Convection-enhanced drug delivery device and method of use
US10912712B2 (en) 2004-03-25 2021-02-09 The Feinstein Institutes For Medical Research Treatment of bleeding by non-invasive stimulation
EP2345451B1 (en) * 2004-12-07 2018-01-24 Novocure Limited Electrodes for applying an electric field in-vivo over an extended period of time
CA2594231C (en) 2004-12-27 2016-04-19 Standen Ltd. Treating a tumor or the like with electric fields at different orientations
US8788044B2 (en) 2005-01-21 2014-07-22 Michael Sasha John Systems and methods for tissue stimulation in medical treatment
US20100049117A1 (en) 2005-04-18 2010-02-25 Pantec Biosolutions Ag Microporator for Porating a Biological Membrane and Integrated Permeant Administering System
EP1937151A4 (en) * 2005-09-19 2011-07-06 Univ Columbia Systems and methods for opening of the blood-brain barrier of a subject using ultrasound
CN112402798B (zh) 2005-10-03 2021-11-16 诺沃库勒有限责任公司 优化电场特征以增加电场在增殖细胞上的效果
US8019414B2 (en) 2006-04-05 2011-09-13 Novocure Ltd. Treating cancer using electromagnetic fields in combination with other treatment regimens
CN100515522C (zh) * 2006-09-18 2009-07-22 郭国祯 促进药物透过血脑屏障的电磁脉冲辐照系统和方法
CN102008782B (zh) * 2006-11-08 2014-11-26 株式会社P·曼德 神经营养因子产生促进装置
WO2009044289A1 (en) 2007-03-06 2009-04-09 Novocure Ltd. Treating cancer using electromagnetic fields in combination with photodynamic therapy
CN101820947A (zh) * 2007-08-14 2010-09-01 诺沃库勒有限公司 用电场治疗寄生物
US8715203B2 (en) 2007-09-17 2014-05-06 Novocure Limited Composite electrode
WO2009047365A1 (en) * 2007-10-12 2009-04-16 Capsulution Nanoscience Ag Drug delivery system
DE102008018170B4 (de) 2008-04-03 2010-05-12 NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen Mikrofluidisches System und Verfahren zum Aufbau und zur anschließenden Kultivierung sowie nachfolgender Untersuchung von komplexen Zellanordnungen
US10245098B2 (en) * 2008-04-29 2019-04-02 Virginia Tech Intellectual Properties, Inc. Acute blood-brain barrier disruption using electrical energy based therapy
US9198733B2 (en) 2008-04-29 2015-12-01 Virginia Tech Intellectual Properties, Inc. Treatment planning for electroporation-based therapies
CN201205406Y (zh) * 2008-05-06 2009-03-11 迟立广 中频交变电场理疗装置
WO2016164930A1 (en) 2015-04-10 2016-10-13 Angiodynamics Inc. System and method for irreversible electroporation with thermally controlled electrodes
CN101318054B (zh) * 2008-07-18 2012-01-25 圣太科医疗科技(上海)有限公司 微电场网引导的肝脏靶向性细胞内药物传递装置
EP2153866A1 (en) * 2008-08-14 2010-02-17 Oncotherm Kft. Portable radiofrequency hyperthermia device with flexible treatment electrode for electric field capacitive coupled energy transfer
WO2010118387A1 (en) 2009-04-09 2010-10-14 Virginia Tech Intellectual Properties, Inc. Integration of very short electric pulses for minimally to noninvasive electroporation
EP2470255A4 (en) 2009-08-24 2013-02-06 Ron L Alterman DEVICE FOR TRANSCEREBRAL ELECTROPHORESIS AND METHOD FOR THEIR USE
CN101698121B (zh) * 2009-10-23 2011-06-22 西安交通大学 促进药物透过血脑屏障的适型超声系统
CN102100945A (zh) * 2009-12-18 2011-06-22 重庆新大地电子有限公司 生物负电子保健治疗仪设备系统
WO2012075337A2 (en) 2010-12-01 2012-06-07 Spinal Modulation, Inc. Directed delivery of agents to neural anatomy
CN202096600U (zh) * 2011-04-09 2012-01-04 南宁市中新森泰科技有限公司 一种电位治疗仪
CN102284132A (zh) * 2011-06-30 2011-12-21 杭州电子科技大学 基于多针形电极的高压脉冲电场治疗装置
US20150126964A1 (en) * 2012-05-13 2015-05-07 Corporation De L'ecole Polytechnique De Montreal Drug delivery across the blood-brain barrier using magnetically heatable entities
US20120323214A1 (en) 2012-05-16 2012-12-20 Totada R Shantha Alzheimer's disease treatment with multiple therapeutic agents delivered to the olfactory region through a special delivery catheter and iontophoresis
CN102836119A (zh) * 2012-08-21 2012-12-26 中国人民解放军第三军医大学第二附属医院 微泡在制备用于联合诊断级超声作为提高肿瘤微血管通透性药物的用途
EP2892611B1 (en) * 2012-09-06 2021-10-27 Covidien LP Neurological treatment system
EP2911736A4 (en) 2012-10-25 2016-06-15 Oncosec Medical Inc electroporation
US9682066B2 (en) 2012-12-04 2017-06-20 University Of Cincinnati Methods of treating primary brain tumors by administering letrozole
US10779875B2 (en) 2013-05-06 2020-09-22 Novocure Gmbh Optimizing treatment using TTfields by changing the frequency during the course of long term tumor treatment
US9655669B2 (en) 2013-05-06 2017-05-23 Novocure Limited Optimizing treatment using TTFields by changing the frequency during the course of long term tumor treatment
US11167133B2 (en) 2015-05-14 2021-11-09 London Health Sciences Centre Research Inc. Intratumoral modulation therapy
CN106333926A (zh) * 2015-07-10 2017-01-18 复旦大学 一种稳定性多肽介导跨屏障膜的脑部肿瘤多重靶向递药系统
US9910453B2 (en) 2015-09-25 2018-03-06 Novocure Limited High voltage, high efficiency sine wave generator with pre-set frequency and adjustable amplitude
US10188851B2 (en) 2015-10-28 2019-01-29 Novocure Limited TTField treatment with optimization of electrode positions on the head based on MRI-based conductivity measurements
US10821283B2 (en) 2016-04-04 2020-11-03 Novocure Gmbh Reducing motility of cancer cells using tumor treating fields (TTFields)
US20180001075A1 (en) 2016-06-30 2018-01-04 Novocure Limited Arrays for Longitudinal Delivery of TTFields to a Body
CA2972699A1 (en) * 2016-07-10 2018-01-10 Novocure Limited Synchronizing tumor cells to the g2/m phase using ttfields combined with taxane or other anti-microtubule agents
KR102629400B1 (ko) 2016-08-18 2024-01-24 노보큐어 리미티드 종양치료장을 전달하기 위한 어레이들 내의 온도 측정
DK3554631T3 (da) 2016-12-13 2022-05-30 Novocure Gmbh Behandling af patienter med ttfields med elektrodepositionerne optimeret under anvendelse af deformerbare skabeloner
WO2018134733A1 (en) 2017-01-19 2018-07-26 Moshe Giladi System for viewing cell cultures under a microscope whilst applying ttfields
IL277290B2 (en) * 2018-03-12 2024-12-01 Tel Hashomer Medical Res Infrastructure & Services Ltd Method for altering blood-brain barrier permeability
US10953209B2 (en) 2018-03-28 2021-03-23 Board Of Regents Of The University Of Texas System Treating tumors using TTFields combined with a PARP inhibitor
WO2019197973A1 (en) 2018-04-09 2019-10-17 Moshe Giladi Treating tumors with ttfields and an aurora kinase inhibitor
KR102687814B1 (ko) 2018-04-10 2024-07-24 지브 봄존 서로 다른 반복 시간을 가지는 두 개의 MRI 이미지들로부터 얻어진 1MHz 미만 저주파 교류 전도도 추산치
CN116159242A (zh) 2018-07-03 2023-05-26 埃德温·阊 使用交变电场提高细胞膜通透性
KR102794415B1 (ko) 2018-07-10 2025-04-09 노보큐어 게엠베하 교류 전기장을 사용한 바이러스 감염 억제
EP3892219B1 (en) * 2018-08-23 2022-06-01 Novocure GmbH Using alternating electric fields to increase permeability of the blood brain barrier

Similar Documents

Publication Publication Date Title
JP2021192835A5 (enExample)
CY1123411T1 (el) Μεθοδοι για την θεραπευτικη αντιμετωπιση πνευμονικων μη-φυματικων μυκοβακτηριακων λοιμωξεων
JP2015522522A5 (enExample)
MY179696A (en) Compositions and methods comprising bupropion or related compounds and dextromethorphan
JP2015517350A5 (enExample)
ME03745B (me) Supstituisani indazoli, postupak za njihovo dobijanje, farmaceutski preparati, koji·ih sadrže, kao i njihova upotreba za proizvodnju lekova
JP2007527914A5 (enExample)
HRP20250250T1 (hr) Derivati 7‑benzil‑4‑(2‑metilbenzil)‑2,4,6,7,8,9‑heksahidroimidazo[1,2‑a]pirido[3,4‑e] pirimidin‑5(1h)‑ona, njihove soli i njihova upotreba u terapiji
JP2016513640A5 (enExample)
HRP20250119T1 (hr) Kdm1a inhibitor i njegova primjena u terapiji
JP2021504412A5 (enExample)
CL2014002935A1 (es) Metodo para tratar un paciente humano con esclerosis multiple con laquinimod, en una dosis diaria de alrededor de 1,2mg; un aforma de dosificacion unitaria oral de 1,2 mg de laquinimod y un portador
EA033054B1 (ru) Производное глутаримидов, его применение, фармацевтическая композиция на его основе, способ его получения
CL2012003012A1 (es) Composicion farmaceutica oral de liberacion prolongada que comprenden a) al menos un material de liberacion prolongada y b) hidromorfona o una sal y naloxona o una sal en una relacion 2:1 a 1:3; metodo de preparacion.
FI2683245T4 (fi) Menetelmiä ja koostumuksia masennuksen hoitamiseen syklobentsapriiniä käyttämällä
PH12016500142A1 (en) Vesicles
JP2015512948A5 (enExample)
ECSP16005208A (es) Composición farmacéutica anti-tuberculosis estable en una forma de un comprimido recubierto que comprende gránulos de isoniazid y gránulos de rifapentina y su proceso de preparación
JP2017517561A5 (enExample)
CL2016000183A1 (es) Composición farmacéutica anti-tuberculosis estable en una forma de un comprimido redispersable que comprende gránulos de isoniazid y gránulos de rifapentina y su proceso de preparación
WO2012150829A3 (ko) 신규한 트리아졸로피리딘 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 포함하는 약학적 조성물
UA75867U (uk) Спосіб комплексного лікування стабільної стенокардії напруги
RU2011108787A (ru) Способ лечения больных красным плоским лишаем слизистой полости рта
RU2015122823A (ru) Способ лечения печёночной энцефалопатии у больных циррозом печени
UA93930U (uk) Спосіб лікування дерматофітозів собак